Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
1.00 Jul 23, 4:02PM EDT
Prev Close:1.00
Open:N/A
Bid:1.01 x 2000
Ask:1.04 x 4700
1y Target Est:3.50
Beta:0.93
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:N/A - N/A
52wk Range:0.65 - 4.00
Volume:2,000
Avg Vol (3m):798,902
Market Cap:57.92M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUC 0.00%57.92M
AGEN189.82M
DNDN336.59M
STML159.94M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Jun-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback